Headlines

Booz Allen Hamilton Holding Corporation And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – Booz Allen Hamilton Holding Corporation (BAH), Williams Companies (WMB), Gilead Sciences (GILD) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Booz Allen Hamilton Holding Corporation (BAH)

86.7% Payout Ratio

Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of artificial intelligence, such as machine learning, deep learning; data science, such as data engineering and predictive modeling; automation and decision analytics; and quantum computing. In addition, the company designs, develops, and implements solutions built on contemporary methodologies and modern architectures; delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.

Earnings Per Share

As for profitability, Booz Allen Hamilton Holding Corporation has a trailing twelve months EPS of $2.03.

PE Ratio

Booz Allen Hamilton Holding Corporation has a trailing twelve months price to earnings ratio of 55.47. Meaning, the purchaser of the share is investing $55.47 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.61%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 1.88 and the estimated forward annual dividend yield is 1.68%.

Sales Growth

Booz Allen Hamilton Holding Corporation’s sales growth is 11.5% for the present quarter and 13% for the next.

Yearly Top and Bottom Value

Booz Allen Hamilton Holding Corporation’s stock is valued at $112.61 at 08:23 EST, below its 52-week high of $113.16 and way above its 52-week low of $87.99.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Booz Allen Hamilton Holding Corporation’s EBITDA is 2.49.

2. Williams Companies (WMB)

81.25% Payout Ratio

The Williams Companies, Inc., together with its subsidiaries, operates as an energy infrastructure company primarily in the United States. It operates through Transmission & Gulf of Mexico, Northeast G&P, West, and Gas & NGL Marketing Services segments. The Transmission & Gulf of Mexico segment comprises Transco and Northwest natural gas pipelines; and natural gas gathering and processing, and crude oil production handling and transportation assets in the Gulf Coast region, as well as various petrochemical and feedstock pipelines. The Northeast G&P segment engages in the midstream gathering, processing, and fractionation activities in the Marcellus Shale region primarily in Pennsylvania and New York, and the Utica Shale region of eastern Ohio. The West segment comprises gas gathering, processing, and treating operations in the Rocky Mountain region of Colorado and Wyoming, the Barnett Shale region of north-central Texas, the Eagle Ford Shale region of South Texas, the Haynesville Shale region of northwest Louisiana, and the Mid-Continent region, which includes the Anadarko, Arkoma, and Permian basins; and operates natural gas liquid (NGL) fractionation and storage facilities in central Kansas near Conway. The Gas & NGL Marketing Services segment provides wholesale marketing, trading, storage, and transportation of natural gas for natural gas utilities, municipalities, power generators, and producers; risk and asset management; and NGL marketing services. The company owns and operates 33,000 miles of pipelines, 29 processing facilities, 7 fractionation facilities, and approximately 24 million barrels of NGL storage capacity. The Williams Companies, Inc. was founded in 1908 and is headquartered in Tulsa, Oklahoma.

Earnings Per Share

As for profitability, Williams Companies has a trailing twelve months EPS of $2.08.

PE Ratio

Williams Companies has a trailing twelve months price to earnings ratio of 16.07. Meaning, the purchaser of the share is investing $16.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.96%.

Volume

Today’s last reported volume for Williams Companies is 3791990 which is 48.85% below its average volume of 7414200.

3. Gilead Sciences (GILD)

66.52% Payout Ratio

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Earnings Per Share

As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.43.

PE Ratio

Gilead Sciences has a trailing twelve months price to earnings ratio of 17.47. Meaning, the purchaser of the share is investing $17.47 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.11%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 4.03%.

Yearly Top and Bottom Value

Gilead Sciences’s stock is valued at $77.38 at 08:23 EST, way below its 52-week high of $89.74 and way above its 52-week low of $59.27.

Volume

Today’s last reported volume for Gilead Sciences is 3627450 which is 34.82% below its average volume of 5565730.

Previous days news about Gilead Sciences (GILD)

  • According to Zacks on Wednesday, 12 July, "The fund has a basket of 268 securities and has major allocations to companies like Vertex Pharmaceuticals (VRTX Quick QuoteVRTX – Free Report) , Amgen (AMGN Quick QuoteAMGN – Free Report) and Gilead Sciences (GILD Quick QuoteGILD – Free Report) , with shares of 8.49%, 8.16% and 7.98%, respectively.", "The fund has major allocations in Amgen (12.33%), Gilead Sciences (9.05%) and Vertex Pharmaceuticals (8.46%), each with a Zacks ETF Rank #4 (Sell). "

4. Sandy Spring Bancorp (SASR)

35.23% Payout Ratio

Sandy Spring Bancorp, Inc. operates as the bank holding company for Sandy Spring Bank that provides commercial and retail banking, mortgage, private banking, and trust services to individuals and businesses. It operates through three segments: Community Banking, Insurance, and Investment Management. The Community Banking segment offers financial products and services, including various loan and deposit products. Its loan products include commercial real estate loans, commercial construction loans, and other commercial loans; residential real estate loans; and consumer loans comprising home equity loans and lines, installment loans, and personal lines of credit. The Insurance segment provides general insurance agency services and annuities, such as commercial, personal, and medical liability lines. The Investment Management segment offers investment management and financial planning, including cash flow analysis, investment review, tax and retirement planning, insurance analysis, and estate planning to individuals, families, small businesses, and associations. It also provides personal trust and wealth management services. The company operates a network of approximately 50 locations in Maryland, Northern Virginia, and Washington D.C. Sandy Spring Bancorp, Inc. was founded in 1868 and is headquartered in Olney, Maryland.

Earnings Per Share

As for profitability, Sandy Spring Bancorp has a trailing twelve months EPS of $3.84.

PE Ratio

Sandy Spring Bancorp has a trailing twelve months price to earnings ratio of 5.91. Meaning, the purchaser of the share is investing $5.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.48%.

Leave a Reply

Your email address will not be published. Required fields are marked *